WILMINGTON – The Delaware State Chamber of Commerce announced Wednesday that Hervé Hoppenot, the CEO of Wilmington-based Incyte Corp., will be the keynote speaker at its 187th Annual Dinner to be held Jan. 29, 2024.
The Annual Dinner is the largest of the state chamber’s annual events, drawing over 1,000 business leaders, dignitaries, and elected officials to the Chase Center on the Riverfront. The evening’s program will include the presentation of the Josiah Marvel Cup award in honor of the memory of Josiah Marvel, who reorganized and was the first president of the modern-day state chamber.
Incyte, a biopharmaceutical company founded in Wilmington in 2002, has grown into a global organization with more than 2,400 employees and a robust portfolio of treatments in oncology and inflammation and autoimmunity that are delivered to patients worldwide.
Hoppenot joined Incyte in 2014 as president and CEO and was appointed chairman of the Board of Directors in 2015. During his tenure, Incyte’s revenue has grown from $511 million in 2014 to $3.4 billion last year, and the company has tripled the number of clinical candidates in its portfolio. With global headquarters based in Wilmington, Incyte has expanded geographically and has operations in North America, Europe and Asia.
“I am honored to address Delaware’s vibrant and diverse business community at the Delaware State Chamber of Commerce’s 187th Annual Dinner,” Hoppenot said in a statement. “I look forward to sharing the Incyte story and how our innovative science is making an impact on the practice of medicine around the world.”
Registration for the 187th Annual Dinner can be found online at https://web.dscc.com//events/185th-Annual-Dinner-2675/details. For more information, contact Kelly Basile at kbasile@dscc.com or 302-576-6564.
